Correction: Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.

Correction made to previous reference to EU Market Abuse Regulation

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.

The presentation of the Q2-2023 interim report for the period April – June 2023 will be held on July 20 at 10:00 CEST. Redeye's equity analyst Christian Binder will host the live broadcast and moderate the Q&A.

For more information on how to register, please visit https://investor.mentice.com/.

The presentation will be held in English. Participants are advised to register in advance.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Join us today

To always stay on top within the field of medical simulation and its development subscribe to our news and resource list

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Correction: Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.

Join us today

Other News